Steve Hoerter

Insider profile

Currently holds positions in Ignyta Inc, Constellation Pharmaceuticals Inc and Deciphera Pharmaceuticals Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 84% 68% 82%
Transactions
5 20% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Ignyta Inc Dec. 8, 2016 -
Independent Director Constellation Pharmaceuticals Inc Sept. 4, 2018 -
President, Chief Executive Officer, Director Deciphera Pharmaceuticals Inc March 18, 2019 -
Chief Commercial Officer Agios Pharmaceuticals, Inc. Feb. 16, 2016 - March 15, 2019
Senior Vice President, Chief Commercial Officer Clovis Oncology Inc Aug. 29, 2011 - Jan. 25, 2016
Steve Hoerter's trades of MBX Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
212.35
Quantity 44,697 -44.7%
Value US$1,001,264
Transaction date
Sale
Price
68.00
Quantity 5,000 -31.4%
Value US$340,000
Transaction date
Sale
Price
66.01
Quantity 5,000 -31.4%
Value US$330,050
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-20 2025-10-17
B Purchase
44,697 -44.7%
212.35
US$1,001,264 		44,697 -44.7% 212.35 US$1,001,264
2023-12-14 2023-12-13
S Sale
77,169 +0.9%
492.35
US$1,572,527 		77,169 +0.9% 492.35 US$1,572,527
2023-10-31 2023-10-30
S Sale
70,225 -25.6%
281.83
US$4,696,375 		70,225 -25.6% 281.83 US$4,696,375
2023-03-23 2023-03-21
PlS Planned sale
7,500 -100.0%
15.57
US$116,782 		7,500 -100.0% 15.57 US$116,782
2023-02-16 2023-02-14
PlS Planned sale
30,045 -80.0%
16.00
US$480,720 		30,045 -80.0% 16.00 US$480,720
2019-03-05 2019-03-04
S Sale
5,000 -31.4%
68.00
US$340,000 		5,000 -31.4% 68.00 US$340,000
2019-03-05 2019-03-01
S Sale
5,000 -31.4%
66.01
US$330,050 		5,000 -31.4% 66.01 US$330,050
2018-07-27 2018-07-25
PlS Planned sale
2,050 -100.0%
84.58
US$173,389 		2,050 -100.0% 84.58 US$173,389
2018-06-26 2018-06-22
PlS Planned sale
2,050 -100.0%
97.58
US$200,039 		2,050 -100.0% 97.58 US$200,039
2018-05-29 2018-05-23
PlS Planned sale
2,050 -100.0%
85.76
US$175,808 		2,050 -100.0% 85.76 US$175,808
2018-04-25 2018-04-23
PlS Planned sale
2,050 -100.0%
85.95
US$176,198 		2,050 -100.0% 85.95 US$176,198
2018-03-26 2018-03-22
PlS Planned sale
2,050 -100.0%
84.65
US$173,532 		2,050 -100.0% 84.65 US$173,532
2018-02-26 2018-02-22
PlS Planned sale
2,050 -100.0%
78.63
US$161,192 		2,050 -100.0% 78.63 US$161,192
2018-01-25 2018-01-23
PlS Planned sale
25,000 -100.0%
74.83
US$1,870,750 		25,000 -100.0% 74.83 US$1,870,750